The double blind phase-II results indicate that the combination might be safe and effectivenes was signifficatly higher in the combination group.
Abstract
--Frank
Tysabri + Copaxone trial results
Tysabri + Copaxone trial results
Treatment: Gilenya since 01/2011, CCSVI both IJV ballooned 09/2010, Tysabri stopped after 24 Infusions and positive JCV antibody test, after LDN, ABX Wheldon Regime for 1 year.